Amdocs Statistics
Total Valuation
Amdocs has a market cap or net worth of $6.68 billion. The enterprise value is $7.49 billion.
| Market Cap | 6.68B |
| Enterprise Value | 7.49B |
Important Dates
The last earnings date was Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | Jun 30, 2026 |
Share Statistics
Amdocs has 106.16 million shares outstanding. The number of shares has decreased by -4.14% in one year.
| Current Share Class | 106.16M |
| Shares Outstanding | 106.16M |
| Shares Change (YoY) | -4.14% |
| Shares Change (QoQ) | -0.96% |
| Owned by Insiders (%) | 1.18% |
| Owned by Institutions (%) | 101.30% |
| Float | 103.89M |
Valuation Ratios
The trailing PE ratio is 12.34 and the forward PE ratio is 7.96. Amdocs's PEG ratio is 0.94.
| PE Ratio | 12.34 |
| Forward PE | 7.96 |
| PS Ratio | 1.43 |
| Forward PS | 1.38 |
| PB Ratio | 1.94 |
| P/TBV Ratio | 47.93 |
| P/FCF Ratio | 9.77 |
| P/OCF Ratio | 8.37 |
| PEG Ratio | 0.94 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.31, with an EV/FCF ratio of 11.03.
| EV / Earnings | 13.72 |
| EV / Sales | 1.62 |
| EV / EBITDA | 7.31 |
| EV / EBIT | 9.13 |
| EV / FCF | 11.03 |
Financial Position
The company has a current ratio of 0.98, with a Debt / Equity ratio of 0.31.
| Current Ratio | 0.98 |
| Quick Ratio | 0.74 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 0.98 |
| Debt / FCF | 1.57 |
| Interest Coverage | 22.61 |
Financial Efficiency
Return on equity (ROE) is 15.86% and return on invested capital (ROIC) is 15.68%.
| Return on Equity (ROE) | 15.86% |
| Return on Assets (ROA) | 8.16% |
| Return on Invested Capital (ROIC) | 15.68% |
| Return on Capital Employed (ROCE) | 17.03% |
| Weighted Average Cost of Capital (WACC) | 5.96% |
| Revenue Per Employee | $171,403 |
| Profits Per Employee | $20,236 |
| Employee Count | 26,969 |
| Asset Turnover | 0.74 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Amdocs has paid $134.71 million in taxes.
| Income Tax | 134.71M |
| Effective Tax Rate | 19.70% |
Stock Price Statistics
The stock price has decreased by -31.26% in the last 52 weeks. The beta is 0.41, so Amdocs's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | -31.26% |
| 50-Day Moving Average | 64.25 |
| 200-Day Moving Average | 75.65 |
| Relative Strength Index (RSI) | 48.13 |
| Average Volume (20 Days) | 1,041,043 |
Short Selling Information
The latest short interest is 5.38 million, so 6.13% of the outstanding shares have been sold short.
| Short Interest | 5.38M |
| Short Previous Month | 5.12M |
| Short % of Shares Out | 6.13% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.90 |
Income Statement
In the last 12 months, Amdocs had revenue of $4.62 billion and earned $545.76 million in profits. Earnings per share was $5.00.
| Revenue | 4.62B |
| Gross Profit | 1.75B |
| Operating Income | 820.09M |
| Pretax Income | 683.86M |
| Net Income | 545.76M |
| EBITDA | 1.02B |
| EBIT | 820.09M |
| Earnings Per Share (EPS) | $5.00 |
Balance Sheet
The company has $214.50 million in cash and $1.07 billion in debt, with a net cash position of -$853.30 million or -$8.04 per share.
| Cash & Cash Equivalents | 214.50M |
| Total Debt | 1.07B |
| Net Cash | -853.30M |
| Net Cash Per Share | -$8.04 |
| Equity (Book Value) | 3.42B |
| Book Value Per Share | 31.86 |
| Working Capital | -30.27M |
Cash Flow
In the last 12 months, operating cash flow was $792.85 million and capital expenditures -$114.11 million, giving a free cash flow of $678.74 million.
| Operating Cash Flow | 792.85M |
| Capital Expenditures | -114.11M |
| Depreciation & Amortization | 204.72M |
| Net Borrowing | 250.00M |
| Free Cash Flow | 678.74M |
| FCF Per Share | $6.39 |
Margins
Gross margin is 37.79%, with operating and profit margins of 17.74% and 11.81%.
| Gross Margin | 37.79% |
| Operating Margin | 17.74% |
| Pretax Margin | 14.79% |
| Profit Margin | 11.81% |
| EBITDA Margin | 22.17% |
| EBIT Margin | 17.74% |
| FCF Margin | 14.68% |
Dividends & Yields
This stock pays an annual dividend of $2.28, which amounts to a dividend yield of 3.63%.
| Dividend Per Share | $2.28 |
| Dividend Yield | 3.63% |
| Dividend Growth (YoY) | 8.95% |
| Years of Dividend Growth | 14 |
| Payout Ratio | 43.87% |
| Buyback Yield | 4.14% |
| Shareholder Yield | 7.78% |
| Earnings Yield | 8.23% |
| FCF Yield | 10.23% |
Analyst Forecast
The average price target for Amdocs is $81.21, which is 29.01% higher than the current price. The consensus rating is "Buy".
| Price Target | $81.21 |
| Price Target Difference | 29.01% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 4.10% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Amdocs has an Altman Z-Score of 4.61 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.61 |
| Piotroski F-Score | 5 |